Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

TriSalus Life Sciences (TLSI) Leases (2022 - 2026)

TriSalus Life Sciences has reported Leases over the past 5 years, most recently at $830000.0 for Q1 2026.

  • For Q1 2026, Leases fell 27.0% year-over-year to $830000.0; the TTM value through Mar 2026 reached $830000.0, down 27.0%, while the annual FY2025 figure was $861000.0, 28.84% down from the prior year.
  • Leases for Q1 2026 was $830000.0 at TriSalus Life Sciences, down from $861000.0 in the prior quarter.
  • Over five years, Leases peaked at $1.4 million in Q3 2024 and troughed at $830000.0 in Q1 2026.
  • A 5-year average of $1.1 million and a median of $1.2 million in 2023 define the central range for Leases.
  • Biggest five-year swings in Leases: rose 13.98% in 2024 and later tumbled 37.63% in 2025.
  • Year by year, Leases stood at $1.4 million in 2022, then decreased by 14.63% to $1.2 million in 2023, then grew by 2.63% to $1.2 million in 2024, then fell by 28.84% to $861000.0 in 2025, then fell by 3.6% to $830000.0 in 2026.
  • Business Quant data shows Leases for TLSI at $830000.0 in Q1 2026, $861000.0 in Q4 2025, and $890000.0 in Q3 2025.